文献速递冠心病

急性冠脉综合征患者服药依从性的决定因素:一项随机临床试验的二次分析

Determinants of medication adherence in patients with acute coronary syndrome: a secondary analysis of a randomised clinical trial.
PubMed 文献 · Heart · 2025-05-02

本研究为TEXTMEDS随机临床试验的二次分析,纳入澳大利亚18家医院1424例ACS患者,评估6个月和12个月时对指南推荐二级预防药物的依从性。多因素分析显示,服药总数多和参加心脏康复与依从性正相关,女性和躯体残疾与依从性负相关。

要点

  • 服药总数多和参加心脏康复与ACS后二级预防用药依从性正相关。
  • 女性和躯体残疾与较低的服药依从性相关。
  • 随访中关注上述因素可能有助于改善依从性。

核心结论

  • 社会人口学和临床因素可能影响ACS患者对二级预防药物的依从性。

研究设计与样本

  • TEXTMEDS单盲随机临床试验的二次分析,纳入澳大利亚18家医院1424例ACS患者,最终分析1379例有完整依从性数据者,平均年龄58.5±10.7岁,男性1095例(79.4%)。

主要发现

  • 服药总数较多与6个月和12个月时心血管药物依从性正相关(OR 1.33;95%CI 1.25–1.42)。
  • 参加心脏康复项目与依从性正相关(OR 1.47;95%CI 1.17–1.86)。
  • 女性与较低依从性相关(OR 0.67;95%CI 0.50–0.90)。
  • 躯体残疾与较低依从性相关(OR 0.43;95%CI 0.23–0.77)。

关键数值与推荐

  • 依从定义为6个月和12个月两个时间点,对全部五类指南推荐药物(无禁忌时)服用比例均>80%(过去1个月>24/30天)。

临床怎么用

  • 随访中应识别女性、躯体残疾等低依从风险患者,并鼓励参加心脏康复以改善依从性。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary heart disease (CHD) remains a leading cause of mortality and disability worldwide. Approximately half of the patients who have had a prior hospital admission for CHD will have a recurrent coronary event, with the majority of these occurring within 12 months. Despite well-established evidence-based therapies, medication non-adherence is highly prevalent and reasons for medication non-adherence are poorly understood. This study evaluates factors influencing adherence to secondary prevention medications in people with acute coronary syndrome (ACS). METHODS: We performed a secondary analysis of TEXT messages to improve MEDication adherence and Secondary prevention after ACS (TEXTMEDS), a single-blind randomised clinical trial of 1424 patients with ACS from 18 hospitals across Australia. The primary outcome was self-reported medication adherence to each of up to five classes of guideline-recommended cardioprotective medications indicated for secondary prevention after ACS. Patients were followed up at 6-month and 12-month time points and were defined as adherent if at both time points, the proportion of indicated medications taken was >80% (>24/30 days in the preceding 1 month) for all five classes if not otherwise contraindicated. Logistic regression analysis and the Least Absolute Shrinkage and Selection Operator regularisation technique were used to assess the effect of sociodemographic and clinical factors on medication adherence. RESULTS: The analyses included 1379 participants with complete adherence data (mean age 58.5±10.7 years; 1095 (79.4%) men). The following variables were associated with adherence to cardiovascular medications at both 6 and 12 months: greater number of total medications taken (OR: 1.33; 95% CI: 1.25 to 1.42) and attending a cardiac rehabilitation programme (1.47; 95% CI: 1.17 to 1.86). In contrast, female sex (0.67; 95% CI: 0.50 to 0.90) and physical disability (0.43; 95% CI: 0.23 to 0.77) were associated with lower likelihood of medication adherence. CONCLUSIONS: Sociodemographic and clinical factors may influence medication adherence. Greater awareness, discussion and monitoring of these factors during patient follow-up may help improve medication adherence. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry; URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448; registration number: ACTRN12613000793718.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Kha, Min, Marschner, et al. Determinants of medication adherence in patients with acute coronary syndrome: a secondary analysis of a randomised clinical trial. Heart. 2025. PMID: 39819620. doi:10.1136/heartjnl-2024-325144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。